Comgest Growth Europe ex UK GBP SU H AccRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 12.5 | 32.8 | -21.6 | 25.5 | 6.3 | |
+/-Cat | - | - | - | - | - | |
+/-B’mrk | - | - | - | - | - | |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 16/05/2024 | GBP 29.34 | |
Day Change | -0.24% | |
Morningstar Category™ | Other Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | IE00BRTM4M55 | |
Fund Size (Mil) 16/05/2024 | GBP 345.77 | |
Share Class Size (Mil) 16/05/2024 | GBP 37.59 | |
Max Initial Charge | - | |
Ongoing Charge 20/02/2023 | 0.93% |
Investment Objective: Comgest Growth Europe ex UK GBP SU H Acc |
The investment objective of the Fund is to achieve capital appreciation by creating a professionally managed portfolio consisting of what, in the opinion of the Investment Manager, are high quality long-term growth companies having their headquarters or carrying out their predominant activities in any European country with the exception of the United Kingdom. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Franz Weis 18/12/2014 | ||
Alistair Wittet 18/12/2014 | ||
Click here to see others | ||
Inception Date 18/12/2014 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Comgest Growth Europe ex UK GBP SU H Acc | 31/01/2024 |
|
|
Top 5 Holdings | Sector | % |
ASML Holding NV | Technology | 8.40 |
Novo Nordisk A/S Class B | Healthcare | 7.45 |
Accenture PLC Class A | Technology | 5.03 |
Essilorluxottica | Healthcare | 4.60 |
Straumann Holding AG | Healthcare | 3.91 |
Increase Decrease New since last portfolio | ||
Comgest Growth Europe ex UK GBP SU H Acc |